Blog — Insulin Resistance

What is Cardiometabolic Risk?

Publié par Behcet Bicakci le

What is Cardiometabolic Risk? Cardiometabolic risk refers to a collection of conditions linked to obesity and insulin resistance that increase the chances of developing type 2 diabetes, heart disease, or both. These risks rarely occur in isolation—when one appears, others often follow. That’s why proactive screening is so important.

Plus →


Understanding Cardio Metabolic Risk – A Silent Threat We Can’t Ignore

Publié par Behcet Bicakci le

Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors...

Plus →


The Obesity Epidemic in the UK – A Hormonal Perspective on a Growing Crisis

Publié par Behcet Bicakci le

The UK is facing a growing obesity crisis, with two-thirds of adults and a rising number of children classified as overweight or obese. A recent UK Parliament briefing highlights alarming trends, including regional and ethnic disparities and increased risks linked to socioeconomic status. While public health strategies continue to evolve, addressing the hormonal root of weight gain may offer a more effective, personalized solution. ZRT Laboratory’s Weight Management Profile helps uncover hidden hormonal imbalances—such as elevated cortisol, low testosterone, or thyroid dysfunction—that contribute to stubborn fat gain, poor metabolism, and increased disease risk.

Plus →


The Interplay of Metabolic Health, Hormones, and NAFLD

Publié par Behcet Bicakci le

By Dr.Tracy Tranchitella, ND-ZRT Laboratory Non-Alcoholic Fatty Liver Disease (NAFLD) has become a primary cause of chronic liver disease, impacting a large portion of the global population. NAFLD is characterized by the buildup of excess fat in the liver, unrelated to alcohol use, and is strongly associated with metabolic syndrome—a group of conditions that raise the risk of heart disease, stroke, and diabetes. Factors contributing to metabolic syndrome may also play a role in the development of NAFLD, but underlying endocrine disorders can further drive the onset and progression of this widespread liver condition. Moreover, environmental and chemical toxins may...

Plus →


Insulin Resistance: Understanding Symptoms and Exploring Dried Blood Spot Testing for Diagnosis

Publié par Ben White le

Insulin is a hormone produced by the pancreas that plays a crucial role in regulating blood sugar levels. However, when the body becomes resistant to the effects of insulin, a condition known as insulin resistance develops. Insulin resistance is a growing concern worldwide and is closely linked to conditions like type 2 diabetes, obesity, and metabolic syndrome. In this blog, we will delve into the symptoms of insulin resistance and explore the potential of dried blood spot testing as a diagnostic tool. Additionally, we will discuss various treatment options available to manage insulin resistance effectively. Understanding Insulin Resistance: Insulin resistance...

Plus →